Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q2 2024 Earnings Call Transcript August 9, 2024
Chris Gibson: Hi, everybody. My name is Chris Gibson, Co-Founder and CEO of Recursion, delighted to be joining you on our L(earnings) today. And I’m joined by our Chief R&D and Commercial Officer, Najat Khan and the Interim CEO and I hope very soon to be CSO of Recursion, Interim CEO of Exscientia and soon to be CSO of Recursion Dave Hallett. We are coming to you live from Oxford, UK. We are in the...
